Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Formoterol + Beclometason (ausschließlich Dafo. DOS), ATC R03AK08 für die Zeit 01.01.2026 - 31.03.2026
Original language: German
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- axicorp Pharma GmbH, Bietergemeinschaft ALIUD / STADAPHARM GbR, Chiesi GmbH, Cipla Europe NV, EurimPharm Arzneimittel GmbH, Hormosan Pharma GmbH, kohlpharma GmbH, ratiopharm GmbH, Viatris Healthcare GmbH
- Contract value
- no value published
- Bids received
- 11
- Published
- 28 May 2026
- Awarded
- 1 Jan 2026
- Contract start
- 1 Jan 2026
- Contract end
- 14 Jan 2027estimated
- Region
- Hamburg